| Document |
Document Title |
|
WO/2024/094526A1 |
The present invention relates to 6-diazo-5-oxo-L-norleucine prodrugs having reduced toxicity and increased tumor specificity and to their therapeutic use for treating cancer.
|
|
WO/2024/094827A1 |
The present invention relates to protein ligands against Carbonic Anhydrase IX (CAIX) as target of biomedical relevance. In particular, the highly specific ligands may be able to exclusively interact with antigens expressed on the surfac...
|
|
WO/2024/095863A1 |
The purpose of the present invention is to provide a metal-organic framework (MOF) which readily adsorbs a target substance even when under relatively low pressure. The present invention is a metal-organic framework constituted by specif...
|
|
WO/2024/095862A1 |
The purpose of the present invention is to provide an MOF which has excellent desorption performance. The present invention provides a metal organic framework which is composed of a specific organic ligand and a specific metal ion, where...
|
|
WO/2024/087580A1 |
Disclosed in the present invention are a benzoxazine-functionalized amino-bridged polyaryloxy rare-earth metal complex, and a preparation method therefor and the catalytic use thereof. The preparation method comprises the following steps...
|
|
WO/2024/090836A1 |
The present invention pertains to: a gallium compound; a method for producing same; a thin film deposition composition containing same; and a method for producing a thin film using same. The gallium compound of the present invention has ...
|
|
WO/2024/087156A1 |
A method for synthesizing 4-hydroxy-N,N,2-trimethylbenzimidazole-6-carboxamide. The process comprises: a method of the present invention for synthesizing 4-hydroxy-N,N,2-trimethylbenzimidazole-6-carboxamide. The method has the characteri...
|
|
WO/2024/087419A1 |
Disclosed in the present invention are a nitrogen-containing heterocyclic boronic acid compound, and a preparation method therefor and the use thereof. In the present invention, a three-step reaction is performed using 3-bromo-1-p-toluen...
|
|
WO/2024/088326A1 |
An embodiment of the present application provides an organic compound, comprising a multi-ring structure formed by bonding at least one first structural unit represented by formula (I) and at least one second structural unit represented ...
|
|
WO/2024/090353A1 |
A compound having a structure represented by general formula (1) or (2). The compound has a high luminescent efficiency and excellent durability and has green-light-emitting properties.
|
|
WO/2024/084122A1 |
The present invention relates to the use of BODIPY-derived compounds to detect drugs such as scopolamine, ketamine and cathinones. When the chromophore BODIPY is combined with copper salts, its colour and fluorescence change in the prese...
|
|
WO/2024/081453A1 |
Novel high purity dimethylaluminium chloride compositions are provided that are suitable for semiconductor applications, such as atomic layer etch and aluminum ion implantation. The reduction or minimization of specified gaseous impuriti...
|
|
WO/2024/077407A1 |
Disclosed in the present invention are a chiral reducing agent and a method for synthesizing chiral nicotine. The chiral reducing agent is a compound 1 or a compound 2, or a stereoisomer of the compound 1 and the compound 2. The structur...
|
|
WO/2024/074352A1 |
Provided is a chelate complex comprising (a) a rare earth metal cation M; (b) a chelate ligand of formula (CL1 A) or (CL1 B) c) at least one anionic nucleophilic ligand LN which is coordinated as a further ligand to the rare earth metal ...
|
|
WO/2024/074648A1 |
The present invention relates to a method for precipitating the gadolinium complex of formula (I) from a solution comprising such gadolinium complex by means of mixing a first solution comprising the complex with a second solution, as we...
|
|
WO/2024/075537A1 |
The present invention addresses the problem of providing a reactive compound having excellent storage stability. The present invention relates to a reactive compound represented by formula (1). (In formula (1), Ar1 denotes an aromatic ...
|
|
WO/2024/066619A1 |
The present application provides an organic compound having a general formula of , wherein at least one of ring A, ring A-Y, ring B, ring B-Y, and R has a structure of . The present application also provides a preparation method and use ...
|
|
WO/2024/067923A1 |
The invention relates to a chemical composition, an optoelectronic component (10) comprising at least one chemical composition of this type, and a use of at least one chemical composition of this type in an optolectronic component (10).
|
|
WO/2024/064210A1 |
Disclosed are compounds, compositions, and methods useful for boron neutron capture therapy.
|
|
WO/2024/063095A1 |
The prevent invention provides a radiolabeled tyrosine derivative which has excellent LAT1 selectability, higher retention at a tumor or cancer site, and a degree of clearance that does not cause side effects, and which can be safely man...
|
|
WO/2024/062200A1 |
The invention relates to a method for producing a MOF, wherein a MOF is a structured metal-organic compound comprising a two- or three-dimensional porous network consisting of inorganic entities that are connected by polydentate chelatin...
|
|
WO/2024/063529A1 |
The present invention relates to a novel compound and an MRI contrast medium comprising same, the compound having, as a functional group, flavonoids, which are one of natural products having anti-inflammatory, antioxidant and anti-cancer...
|
|
WO/2024/055196A1 |
The present invention relates to an acceptor-donor-acceptor (A-D-A) type organic compound and a preparation method therefor. The material has a thermal activation delayed fluorescence property; a monomolecular structure presents a face-t...
|
|
WO/2024/055195A1 |
The present invention relates to a high-efficiency organic electroluminescent device and a preparation method therefor. A hole injection layer, a hole transport layer, an electron blocking layer, a light-emitting layer, a hole blocking l...
|
|
WO/2024/058103A1 |
The purpose of the present invention is to provide a compound and a colored resin composition which make it possible to produce an optical filter having improved solvent resistance (and preferably, improved solvent resistance, heat resis...
|
|
WO/2024/059650A2 |
Theranostic agents for targeting Gastrin Releasing Peptide Receptor (GRPR) and Prostate Specific Membrane Antigen (PSMA) expressing cells, and use of these agents for detection, staging, and therapy of primary and metastatic prostate can...
|
|
WO/2024/054972A2 |
The present invention provides a compound having the structure: or salt or ester thereof.
|
|
WO/2024/052549A1 |
The present invention relates to a new class of compounds of general formula (I), to the metal chelates with a metal ion suitable for computed tomography thereof, to the Gd3+ chelate complexes thereof, to methods of preparing said compou...
|
|
WO/2024/052250A1 |
The present invention relates to the use of an aminoborane for the preparation of an alkenylaminoborane from a catalyst-free alkyne or in the presence of a catalyst selected from the group of acids consisting of carboxylic acids, sulfoni...
|
|
WO/2024/049087A1 |
Disclosed in the present invention are a novel compound based on pyclen and an MRI contrast agent comprising same. The novel compound and MRI contrast agent of the present invention are characterized by having a structure represented by ...
|
|
WO/2024/048409A1 |
Provided is a composite obtained by bonding, with high strength, a support having a metal part and a metal-organic framework (MOF). The composite comprises a support having a metal part and a metal-organic framework formed on the surfa...
|
|
WO/2023/008865A9 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule has a structure represented by formula I wherein Ar1 is selected from the group c...
|
|
WO/2024/047571A1 |
The present invention provides new co-crystal derivatives (coformers: Caffeine, Picolinic Acid, Quinaldic Acid, and Pyridoxine) of 4-((1-hydroxy-1,3- dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile (Crisaborole) having varied dissolut...
|
|
WO/2023/240266A9 |
A composition comprising lithium Li+ and boron cluster weakly-coordinating anions and methods of preparing the same are disclosed. The weakly-coordinating boron cluster anion comprises a formula of [BnXx(OR)y]2- or a salt thereof, wherei...
|
|
WO/2024/042952A1 |
The present invention provides: an acid generator which exhibits excellent solubility in a cationically curable compound; and a curable composition which is rapidly cured when subjected to a heat treatment, and which forms a cured produc...
|
|
WO/2024/044536A2 |
The attachment of glucose to drugs and imaging agents enables cancer cell targeting via interactions with GLUT1 overexpressed on the cell surface. The present technology describes a biomimetic approach for the design of a multivalent glu...
|
|
WO/2024/042951A1 |
Provided is an acid generator that has superior solubility in cation-curable compounds. This acid generator includes: a salt (1) of a cation represented by formula (c-1) and a monovalent counter anion; and a salt (2) of a cation repres...
|
|
WO/2024/037635A1 |
The present invention pertains to the biomedical field, and particularly relates to a trifunctional compound comprising a fibroblast activation protein (FAP) targeting moiety. The present invention also relates to a pharmaceutical compos...
|
|
WO/2024/040009A2 |
This invention pertains to the discovery and development of novel inhibitors for Methionine Aminopeptidase 2 (MetAP2). The MetAP2 inhibitors have demonstrated efficacy in therapeutic applications for treating various conditions, includin...
|
|
WO/2024/038356A1 |
The present disclosure includes synthetic methods for preparing certain substituted 1-aryl-1'-heteroaryl and 1,1'-biheteroaryl compounds, which can be used to treat, ameliorate, and/or prevent hepatitis B virus (HBV) infections in a pati...
|
|
WO/2024/038842A1 |
The present invention relates to a compound represented by formula (I) (in the formula, R1 is a C1-4 alkyl group or the like, and A1 and A2 are each independently a group, etc. represented by formula (II), in which R2 and R3 are each ind...
|
|
WO/2024/036097A1 |
Provided herein are heteroaromatic macrocyclic ether compounds and isotopologues thereof, or a stereoisomer, or a mixture of stereoisomers thereof, or a pharmaceutically acceptable salt thereof, and methods of treating, preventing or man...
|
|
WO/2024/031919A1 |
The present invention belongs to the field of organic synthesis, and particularly relates to a carbazole fused boron-nitrogen derivative, a preparation method therefor, and the use thereof. The present invention provides the preparation ...
|
|
WO/2024/035871A1 |
Disclosed are compounds, compositions, and methods useful for boron neutron capture therapy.
|
|
WO/2024/023332A1 |
The invention relates to novel silicon-based fluoride acceptor groups (SiFA groups) of the following formulae (Ia, Ib, Ic) as well as to compounds suitable for use in radiopharmacy comprising such groups, wherein R1 and R2 are each a lin...
|
|
WO/2024/024818A1 |
[Problem] To provide a simpler method for producing a high-quality metal-organic structure. [Solution] The method for producing a metal-organic structure according to the present invention comprises: providing a stirrer equipped with a...
|
|
WO/2024/019972A1 |
The described process synthesizes a halide-free single-site borane compound product tris(ortho-carboranyl)borane, or BoCb3. BoCb3 has Lewis superacid properties. The compounds, BoCb3, are thermally stable, and not reactive towards oxygen...
|
|
WO/2023/250157A9 |
Disclosed are compounds for inhibiting lipoamide dehydrogenase (Lpd), and methods of treating tuberculosis.
|
|
WO/2024/016976A1 |
The present invention relates to a FAP-α specific tumor diagnostic imaging agent, in particular, the present invention relates to a compound of formula (I), a FAP-α specific tumor imaging agent formed by coordination of the compound of...
|
|
WO/2024/016963A1 |
Provided are an organic electroluminescent material containing a B-N structure and a use thereof, the general structural formula thereof being as shown in formulas (A) and (B). Based on a conventional B-N resonance structure, in this typ...
|
